HOME › DRUGS › AFAMELANOTIDE
ACTIVE SUBSTANCE / INN

AFAMELANOTIDE

Brand name(s): Scenesse, SCENESSE
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
Protoporphyria, Erythropoietic
NDA210797
ACTIVE SUBSTANCE
Afamelanotide
REGULATORS
FDA · EMA
SPONSORS / MAH
CLIVUNEL INC, Clinuvel Europe Limited
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
SCENESSENDA210797CLIVUNEL INCPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
ScenesseClinuvel Europe LimitedAuthorised22/12/2014Protoporphyria, Erythropoietic

FULL INTELLIGENCE ON AFAMELANOTIDE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →